Related Experiment Video

Updated: Aug 20, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

Hypertension guidelines, meta-analyses and clinical trials: do we assume too much?

Roger E Peverill1

  • 1Centre for Heart and Chest Research, Monash University Department of Medicine, Monash Medical Centre, Melbourne, VIC, Australia. roger.peverill@med.monash.edu.au

The Medical Journal of Australia
|January 18, 2005
PubMed

Insights

Current hypertension guidelines may be unreliable due to varying drug effects and trial limitations. Switching ineffective first-line drugs, rather than adding to them, may improve hypertension control with monotherapy.

Area of Science:

  • Cardiology
  • Pharmacology
  • Clinical Medicine

Background:

  • Major national and international hypertension guidelines exhibit fundamental differences.
  • Antihypertensive agents demonstrate varying efficacy based on patient age and race.
  • Current guidelines may not adequately address individual patient variability.

Purpose of the Study:

  • To evaluate the reliability of current hypertension management guidelines.
  • To explore alternative strategies for optimizing antihypertensive therapy.
  • To assess the potential of monotherapy through drug exchange.

Main Methods:

  • Critical review of existing hypertension guidelines and clinical trial protocols.
  • Analysis of factors influencing antihypertensive drug efficacy, including age and race.
  • Comparison of guideline-recommended add-on therapy versus drug exchange for monotherapy.

Main Results:

  • Guideline recommendations may be questionable due to inherent differences and limitations.
  • Exchanging an ineffective first-line antihypertensive drug can lead to successful monotherapy.
  • Trial protocols often use varying drug doses and combinations, limiting generalizable conclusions.

Conclusions:

  • Reliance on current hypertension guidelines should be approached with caution.
  • Drug exchange as monotherapy presents a viable alternative to add-on strategies.
  • Further research is needed to address long-term effects and individualize treatment.

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.